Abiopharma

🔍 GRAF FINCKENSTEIN FRIEDRICH (Executive)

Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 58,750 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 58,750.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
• F2: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.